Change - Announcement of Cessation::Cessation of Chief Financial Officer - Ms Woo Yeng Yeng

Issuer & Securities

Issuer/ Manager
RAFFLES MEDICAL GROUP LTD
Securities
RAFFLES MEDICAL GROUP LTD - SG1CH4000003 - BSL
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
07-Nov-2026 10:04:18
Status
New
Announcement Sub Title
Cessation of Chief Financial Officer - Ms Woo Yeng Yeng
Announcement Reference
SG261107OTHRNRLJ
Submitted By (Co./ Ind. Name)
Yap Chew Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Cessation of Ms Woo Yeng Yeng as Chief Financial Officer

Additional Details

Name of person
Woo Yeng Yeng
Age
50
Is effective date of cessation known?
Yes
If yes, please provide the date.
31/12/2026
Detailed reason(s) for cessation
To pursue personal interests.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
Yes
If yes, please elaborate.
The Company has undertaken a search for a new Chief Financial Officer. In the meanwhile, the Group Financial Controller, Mrs Kimmy Goh, will cover her duties.

The Board of Directors and the Company would like to record our appreciation to Ms Woo Yeng Yeng, who has served as a Chief Financial Officer since 1 October 2025. We thank her for her contributions and wish her well.
Date of appointment to current position
01/10/2025
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Financial Officer
Role and responsibilities
Responsible for all matters relating to Corporate Finance, Tax, Treasury, Investor Relations, Risk Management, Legal, Leasing and Procurement.
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of independent directors currently resident in Singapore (taking into account this cessation)
5
Do independent directors make up at least one-third of the board (taking into account this cessation)?
Yes
Number of cessations of appointments specified in Mainboard Rule 704(7) or Catalist Rule 704(6) over the past 12 months
2
Shareholding interest in the listed issuer and its subsidiaries
No
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Other Directorships
Past (for the last 5 years)
Please refer to Appendix A attached.
Present
Sport Singapore (Co-opt Audit Committee Member)

Attachments

Ms Woo Yeng Yeng_Appendix A.pdf
Total size =242K